Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity

Science Translational Medicine(2022)10.1126/scitranslmed.abj6824Source: DataRank Database

Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity is a research paper published in Science Translational Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 126 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access126 citations

Download PDF

Cite:

Linked data & code

gen gisaid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 5.80)OA: hybridTopics (34)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (28)

Roanne Keeton ORCID,Thandeka Moyo-Gwete ORCID,Tandile Hermanus ORCID,Prudence Kgagudi,Richard Baguma ORCID

Live enrichment

PubMed:34931886 PMC:PMC9434381 OpenAlex:https://openalex.org/W4200629684

Wellcome Trust

Grant: 104803/Z/14/Z

FIC NIH HHS

Grant: D43 TW010559

Medical Research Council

Grant: MC_PC_19038

NIAID NIH HHS

Grant: R21 AI148027

Rosetrees

Grant: M926

The Francis Crick Institute

Grant: 10218

The Francis Crick Institute

Grant: CC2112

Wellcome Trust

Grant: FC0010218

Wellcome Trust

Grant: 203135/Z/16/Z

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: TMA2016SF-1535

European & Developing Countries Clinical Trials Partnership (EDCTP)

Grant: TMA2017SF-1951

Wellcome Trust

FWCI

5.80

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

hybridLicense: cc-by

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9434381

publisherhttps://doi.org/10.1126/scitranslmed.abj6824

publisherhttps://www.science.org/doi/pdf/10.1126/scitranslmed.abj6824

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34931886

repositoryhttps://figshare.com/articles/journal_contribution/Escape_from_recognition_of_SARS-CoV-2_variant_spike_epitopes_but_overall_preservation_of_T_cell_immunity_/19188299

Fields of Study

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesImmune responses and vaccinationsAntibodies, ViralCOVID-19EpitopesHumansSARS-CoV-2Spike Glycoprotein, CoronavirusSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralEpitopesHumansSpike Glycoprotein, Coronavirus

Keywords

Spike (software development)EpitopeImmunityBETA (programming language)VirologyBiologyImmune recognitionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)NeuroscienceMedicineCoronavirus disease 2019 (COVID-19)ImmunologyImmune systemAntibodyComputer sciencePathologyDiseaseInfectious disease (medical specialty)

Additional file 1 of A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia

10.6084/m9.figshare.26573359.v1figshare

Additional file 1 of A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia

10.6084/m9.figshare.26573359figshare

Additional file 2 of A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia

10.6084/m9.figshare.26573362.v1figshare

Additional file 2 of A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia

10.6084/m9.figshare.26573362figshare

Additional file 3 of A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia

10.6084/m9.figshare.26573365.v1figshare

Additional file 3 of A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia

10.6084/m9.figshare.26573365figshare

Additional file 1 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599849.v1figshare

Additional file 1 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599849figshare

Additional file 2 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599852.v1figshare

Additional file 2 of Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

10.6084/m9.figshare.26599852figshare